Radiofrequency ablation for recurrent parathyroid cancer
Part of Cancer, Hormones & metabolism clinical trials.
This study tests radiofrequency ablation (a heat-based treatment) for parathyroid cancer that has returned after surgery. It's for people who cannot or choose not to have more surgery, and the tumor can be reached with a needle through the skin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and cannot have surgery, or you choose not to.
- Your parathyroid cancer was confirmed by a past surgery and has come back.
- The tumor can be seen on an ultrasound and is a solid nodule (not a cyst or calcified).
- You have stopped taking Cinacalcet, a medicine that lowers calcium.
- Your blood tests show normal clotting and no anemia.
- If you could become pregnant, you will need a negative pregnancy test before the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests radiofrequency ablation (a heat-based treatment) for people with non-cancerous or suspicious thyroid nodules, or small thyroid cancers. It may be an option if you are not a candidate for or choose not to have surgery.
This trial tests using ultrasound-guided heat (thermal ablation) to treat thyroid cancer that has come back in the neck after a prior thyroidectomy. The goal is to destroy the recurrent tumor using a needle-like device, avoiding another surgery for patients whose cancer has not spread elsewhere.
This study tests whether radiofrequency ablation (a heat-based treatment applied through the skin) can safely and effectively cure small, low-risk papillary thyroid cancers. It is designed for people whose tumors are small, have not spread, and who either cannot have surgery or prefer not to.
This study looks at what makes papillary thyroid cancer come back after a heat-based treatment called thermal ablation. It may help doctors better predict recurrence risk and guide follow-up after treatment.
This trial compares two ways of surgically treating localized, recurrent nasopharyngeal cancer: a low-temperature plasma radiofrequency method versus a standard high-frequency cautery method. You might be eligible if your recurrence is limited and can be surgically removed, and you are within the allowed health and age ranges.
This study tracks patients with early-stage kidney cancer (T1a, tumors smaller than 4 cm) who are treated with radiofrequency ablation, a procedure that uses heat to destroy cancer cells. It aims to see how well this treatment works in real-world practice and is only for people whose care team has already recommended this procedure.
Hear when a new Recurrent Parathyroid Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.